What is the preferred single‑dose IV antibiotic regimen (including dose) for prophylaxis that covers Gram‑negative bacilli and obligate anaerobes?

Preferred Single-Dose IV Antibiotic for Gram-Negative and Anaerobic Coverage

For single-dose IV prophylaxis covering Gram-negative bacilli and obligate anaerobes, use ceftriaxone 2 g IV combined with metronidazole 500 mg IV. This combination provides comprehensive coverage against the target organisms with convenient once-daily dosing suitable for prophylactic administration.

Rationale for Antibiotic Selection

Primary Recommendation: Ceftriaxone + Metronidazole

• Ceftriaxone 2 g IV provides excellent coverage against Gram-negative bacilli including Enterobacteriaceae, with once-daily dosing that is ideal for prophylaxis 1.

• Metronidazole 500 mg IV adds essential coverage against obligate anaerobes including Bacteroides fragilis, which is critical for procedures involving the lower gastrointestinal tract 1.

• This combination is specifically recommended by IDSA guidelines for moderate-to-severe infections requiring coverage of both Gram-negative organisms and anaerobes 1.

Alternative Single-Agent Options

If a true single-agent regimen is required (rather than combination):

• Ertapenem 1 g IV provides broad-spectrum coverage including Gram-negative bacilli and obligate anaerobes in a single dose 1.

  • Once-daily dosing makes it practical for prophylaxis 1.
  • Does not cover Pseudomonas aeruginosa, but this is rarely needed for prophylaxis in most clinical scenarios 1.
  • More expensive than combination therapy but offers convenience 1.

• Cefoxitin 1-2 g IV is a second-generation cephalosporin with anaerobic coverage 1.

  • Provides adequate Gram-negative and anaerobic coverage for many prophylactic indications 1.
  • Less expensive than carbapenems 1.

Dosing Specifications

Standard Adult Doses for Prophylaxis:

• Ceftriaxone: 2 g IV as single dose 1
• Metronidazole: 500 mg IV as single dose 1
• Ertapenem: 1 g IV as single dose 1
• Cefoxitin: 1-2 g IV as single dose 1

Clinical Context Considerations

When to Use Combination vs. Single Agent:

• Use ceftriaxone + metronidazole for procedures involving the colon, distal small bowel, or when obstruction is present, as these require reliable anaerobic coverage 1.

• Use ertapenem alone when broad-spectrum single-agent therapy is preferred and Pseudomonas coverage is not needed 1.

• Avoid broader agents (e.g., piperacillin-tazobactam, carbapenems with anti-pseudomonal activity) for routine prophylaxis to preserve these agents for treatment of resistant infections 1.

Important Caveats

• Timing matters: Administer prophylactic antibiotics after fluid resuscitation has been initiated to ensure adequate tissue perfusion and drug distribution 1.

• Antimicrobial stewardship: Avoid using broad-spectrum agents routinely reserved for nosocomial infections (e.g., cefepime, meropenem, imipenem) for community-acquired or prophylactic indications 1.

• Allergy considerations: For patients with β-lactam allergies, consider fluoroquinolone (ciprofloxacin or levofloxacin) plus metronidazole as an alternative combination 1.